The use of EGFR-CD3 bispecific antibody and antigen-specific high avidity T cells to target cancer associated fibroblasts and cancer cells within a melanoma organoid system

      Background: The interactions between cancer cells and cancer-associated fibroblasts (CAFs) in the tumor microenvironment (TME) are important for local tumor progression and metastasis. CAFs make up the majority of the cell population in the TME and can effectively inhibit an immune response by acting as both a physical barrier and immunosuppressive agent. In this report, we developed a novel immune-based approach to treat a solid tumor through the use of melanoma-specific high-avidity cytotoxic T lymphocytes (HACTL) and bispecific antibodies (BsAbs) to target melanoma cells and CAFs.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect